Eurotax Chemo !!hot!! Jun 2026

:

This disparity creates a "Eurotax" problem. Pharmaceutical companies engaging in parallel trade—buying low in one country and selling high in another—can exploit these tax differences. This creates supply shortages in lower-price markets and drives up costs in higher-tax jurisdictions. The push for a "Eurotax" solution involves proposals to standardize the VAT treatment of essential medicines to stop this arbitrage, ensuring that tax policy does not dictate where a cancer patient can receive their medication. Eurotax Chemo

To understand the weight of this issue, one must first define the components. The term "Eurotax" generally refers to the drive within the European Union to harmonize tax bases and rates among member states to prevent competitive devaluations and ensure a level economic playing field. : This disparity creates a "Eurotax" problem